SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to intense speculation surrounding the upcoming Phase 3 REGAL trial results and ongoing volatility driven by a high short interest position. Community discourse remains deeply polarized, with bulls highlighting the potential for a transformative breakthrough in AML treatment and buyout rumors, while bears express significant skepticism over trial design and the company's long-term sustainability.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is drawing intense community focus as traders speculate on potential short-squeeze dynamics and the possibility of a return to higher price levels. While some participants are actively accumulating in hopes of a rapid rally, others remain cautious, debating whether recent volatility represents a genuine trend reversal or a recurring pump-and-dump cycle.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The software sector is currently experiencing a strong rotation as investors pivot from crowded semiconductor momentum toward enterprise SaaS leaders. The community is actively discussing the sector's 'Agentic AI' monetization potential, debating whether this shift represents a sustainable re-rating or another temporary bounce in a volatile market environment.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is drawing intense retail and institutional scrutiny as investors weigh the significant potential of a looming SpaceX partnership against concerns over debt and massive share sell-offs. The stock is currently being driven by a tug-of-war between aggressive short-sellers betting on further downside and value-focused participants who are betting on a major turnaround fueled by aggressive share buybacks and a potential short squeeze.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The VOO ETF is trending as investors aggressively rotate capital from broad indices into targeted semiconductor and AI memory plays amid fluctuating geopolitical tensions. The market is currently focused on navigating S&P 500 index rebalancing and high-conviction institutional rotation as traders weigh compounding long-term growth against short-term macroeconomic uncertainty.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing market attention following FDA approval of Lumvoa for the treatment of thyroid eye disease, with the community closely tracking the company's immediate commercial launch plans and potential for market share capture. Investors are actively debating the stock's valuation, the competitive landscape against existing treatments, and the prospects for long-term growth as the firm transitions into a commercial-stage entity.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is drawing heavy interest as traders leverage Tesla's aggressive innovation narrative and market volatility to capitalize on momentum swings. The community remains deeply divided, with some betting on a long-term rally driven by artificial intelligence and robotics, while others actively trade the leveraged decay to play both sides of the volatility.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is garnering significant investor interest following its preliminary selection for inclusion in the Russell 3000 and Russell Microcap Indexes, with the community actively speculating on the stock's potential as it positions itself at the intersection of AI, energy, and digital infrastructure. Investors are closely monitoring potential catalysts, such as impending hyperscaler tenant announcements, while discussing the structural demand likely to be generated by index fund rebalancing.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh potential European regulatory outcomes against the recent implementation of key billing codes and anticipated milestone payments. The community is actively debating the company's long-term commercial strategy, management's communication, and the impact of upcoming pipeline catalysts on valuation.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is currently trending due to a massive, extended sell-off that has triggered intense community debate over whether the stock is a 'generational buy' at a discounted valuation or facing a structural decline. Investors are aggressively analyzing the company's defensive 'cash cow' status, its heavy use of share buybacks, and its potential for AI monetization against broader concerns about a sector-wide rotation away from high-growth enterprise software.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CTVA
Share Price: $82.84

Contract Selected: Sep 18, 2026 $85 Calls

Buy Zone: $3.44 – $4.25
Target Zone: $5.58 – $6.82
Potential Upside: 53% ROI

Time to Expiration: 128 Days | Updates via https://fxcapta.com/stockinfo/

Every trade is a home run. Over 96% win rate on all trades for the past two years, over 1,000,000+ total trades. Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute financial advice. Trading involves risk, and past performance is not indicative of future results.

Fxcapta

fxcapta.com

StockTwits Web

Corteva Inc


Share Price: $82.84

Contract Selected: Sep 18, 2026 $85 Calls

Buy Zone: $3.44 – $4.25
Target Zone: $5.58 – $6.82
Potential Upside: 53% ROI

Time to Expiration: 128 Days | Updates via 